Globus Medical

Update in progress

GMED (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Globus Medical develops and markets medical devices for musculoskeletal disorders in the US and globally. Its spine line includes pedicle screws, rods, cages, plating, dynamic stabilization, total disc replacement, and interspinous devices; vertebral fracture solutions; biologics; orthopedic trauma systems; and hip/knee arthroplasty components. It offers neuromonitoring, spinal cord stimulation services, and robotic/software platforms (ExcelsiusGPS, Surgimap, Excelsius3D, ExcelsiusHub, ExcelsiusFlex). The company also distributes human tissues. Founded 2003, based in Audubon, PA.

Company score

Sentiment: 0.23; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.15; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.05; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.14; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive